Ranked #1 in Medical Office Building Sales in the U.S. in 2020

With over $1.4 billion in U.S. MOB investment sales volume for 2020, Newmark leads top brokerages and captured a market share of more than 19%.

"As providers continue to experience an unprecedented capital markets environment focus on preserving capital post-COVID-19, we anticipate the continued use of third-party capital for development and growth. Evaluating capital sources and deciding to own or lease will also bolster volume and growth for the medical office sector in 2021." - Todd Perman, CCIM, Vice Chairman, Global Healthcare Services

"COVID-19 certainly created a challenging transaction climate, but it also accelerated the allocation of capital to medical office real estate for investment platforms, which were previously not invested in the sector. Furthermore, allocations increased for those that were already invested. Yields have continued to tighten as investors seek certainty, high-quality real estate, strong-credit characteristics and a hedge against inflation through long-term leases and contractual rent growth. We forecast the continuation of this trend in 2021 and beyond." - Ben Appel, Executive Managing Director, Global Healthcare Services

This ranking showcases Newmark’s in-depth experience in transacting in today’s healthcare real estate environment.


Source: Real Capital Analytics and Newmark Capital Markets Research
*Ranking includes hybrid medical office and life science property, excludes seniors housing and debt placements

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter